上海凯宝：获得痰热清胶囊药品注册证书

Core Viewpoint - Shanghai Kaibao (300039.SZ) has received a drug registration certificate from the National Medical Products Administration for its product, Phlegm-Heat Clearing Capsules, which now includes a new indication for use in the routine treatment of COVID-19, specifically for mild cases presenting with fever, cough, and sore throat [1] Group 1 - The approval of Phlegm-Heat Clearing Capsules will expand the product's applicable range [1] - This development is expected to enhance the market competitiveness and brand recognition of the company [1] - The sales performance of the drug may be influenced by various factors, including national policies and changes in the market environment, leading to uncertainty [1]